Joyflex® One
Sodium hyaluronate 20 mg/ml for intra-articular injection
Medical device
4 ml syringe
1 injection
80 mg
Joyflex One is a single-dose intra-articular injection formulation: a single 4 ml syringe (sodium hyaluronate 2%, 80 mg) covering the full therapeutic course. It responds to the growing preference for simplified, single-use protocols, particularly in high-volume clinical settings.
Same molecular weight and standard line profile, in a configuration that reduces patient access points from three to one.
- Molecular weight 1.2–1.5 million Daltons.
- High viscosity 150,000–290,000 cP
- Dosage: a single injection, 6–12 months coverage.
Specification
Value
Active ingredient
Linear sodium hyaluronate
Molecular weight
1.2–1.5 million Daltons
Viscosity
150,000–290,000 cP
Concentration
80 mg / 4 ml
Osmolarity
270–330 mOsm/kg
pH
6,5–7,5
Volume
4 ml
Origin
Biofermentation
Dosage
1 injection (6/12 months coverage)
Shelf life
36 months
Specification
Value
Active ingredient
Linear sodium hyaluronate
Molecular weight
1.2–1.5 million Daltons
Viscosity
150,000–290,000 cP
Concentration
80 mg / 4 ml
Osmolarity
270–330 mOsm/kg
pH
6,5–7,5
Volume
4 ml
Origin
Biofermentation
Dosage
1 injection (6/12 months coverage)
Shelf life
36 months
Accessible proposition that broadens the prescribing base without displacing the premium positioning of the Proakjn line. The single-dose format is a tangible selling point towards high-volume facilities and markets attentive to patient compliance.
Reference channel
High-volume centres, outpatient clinics that promote single doses and a reduction in visits.
Support included
- Complete technical and clinical documentation (in accordance with current European regulations, in English).
- Presentation materials for the professional, adaptable by market.
- Support with positioning against local competitors.
- Willingness to consider local trade names, subject to regulatory compliance.
Compare the line — Joyflex joint references
Highlighting the column of Joyflex One - the product on this page.
